Biblioteca Digital

96 resultados para Left ventricle hypertrophy

Angiotensin II mediated hypertrophy involves activation of AT2 receptors and upregulation of creatine kinase

Relevância:

20.00% 20.00%

Publicador:

The thiazolidinedione, troglitazone, does not initiate ventricular cardiomyocyte hypertrophy in vitro but may sensitise cardiomyocytes to the hypertrophic effects of serum growth factors

Relevância:

20.00% 20.00%

Publicador:

Evidence for altered signalling mediated by ETB receptors in cardiomyocyte hypertrophy induced by pressure overload in spontaneously hypertensive rat.

Relevância:

20.00% 20.00%

Publicador:

Altered functional responsiveness to neuropeptide Y acting at Y2 receptors in established ventricular cell hypertrophy in spontaneously hypertensive rat

Relevância:

20.00% 20.00%

Publicador:

Altered responsiveness to beta2 adrenoceptor and NPY Y2 receptor stimulation during progression of cardiomyocyte hypertrophy

Relevância:

20.00% 20.00%

Publicador:

ETB receptor involvement and associated mechanisms in endothelin-1 mediated hypertrophy in adult cardiomyocytes

Relevância:

20.00% 20.00%

Publicador:

Increased potency of NPY to attenuate contraction via Y2 receptors during development of cardiomyocyte hypertrophy

Relevância:

20.00% 20.00%

Publicador:

Evidence for enhanced endothelin ETB receptor affinity during the progression of hypertension-induced ventricular cardiomyocyte hypertrophy

Relevância:

20.00% 20.00%

Publicador:

ETB receptor mediated cardiomyocyte hypertrophy in the spontaneously hypertensive rat

Relevância:

20.00% 20.00%

Publicador:

Temporal dependence of the onset of parameters of cardiomyocyte hypertrophy in response to pressure overload

Relevância:

20.00% 20.00%

Publicador:

Evidence for reduced potency of NPY to elicit contraction via Y1 receptors in established cardiomyocyte hypertrophy

Relevância:

20.00% 20.00%

Publicador:

Alterations in ETB receptor characteristics during development of hypertension-induced cardiomyocyte hypertrophy are prevented by bosentan

Relevância:

20.00% 20.00%

Publicador:

Cardiomyocyte hypertrophy following inhibition of nitric oxide synthase by L-NAME

Relevância:

20.00% 20.00%

Publicador:

Direct effects of thiazolidinediones and interactions with growth regulating factors in development of cardiomyocyte hypertrophy

Relevância:

20.00% 20.00%

Publicador:

Upregulation of adrenomedullin and its receptor components in cardiomyocyte hypertrophy induced by NOS inhibition

Relevância:

20.00% 20.00%

Publicador:

«
1
2
3
4
5
6
7
»